Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Nasdaq  -  04:00 2022-07-01 pm EDT
149.95 USD   +4.97%
07/01INSIDER SELL : Moderna
MT
06/30Moderna Files For Canadian Regulatory Approval Of New COVID-19 Booster
MT
06/30U.S. FDA to use existing Omicron booster data to review shots targeting new subvariants -official
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna's CEO Stephane Bancel to Exercise Shares, Intends to Donate Proceeds to Charity

05/24/2022 | 12:25pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about MODERNA, INC.
07/01INSIDER SELL : Moderna
MT
06/30Moderna Files For Canadian Regulatory Approval Of New COVID-19 Booster
MT
06/30U.S. FDA to use existing Omicron booster data to review shots targeting new subvariants..
RE
06/30US FDA wants COVID boosters targeting Omicron BA.4, BA.5 subvariants
RE
06/30Tweaked COVID boosters in US must target newer omicron types
AQ
06/30Moderna Seeks Health Canada Nod For New Double-Protection Covid-19 Booster - Global New..
RE
06/30COVID SCIENCE-Pausing methotrexate improves booster response; first-trimester of pregna..
RE
06/29BioNTech, Pfizer to starting testing universal coronavirus vaccine in H2
RE
06/29Taiwan to receive first doses of Novavax COVID vaccine this week
RE
06/28Pfizer, Moderna to be ready with BA.1-specific COVID boosters
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 22 079 M - -
Net income 2022 11 509 M - -
Net cash 2022 18 531 M - -
P/E ratio 2022 5,50x
Yield 2022 -
Capitalization 59 644 M 59 644 M -
EV / Sales 2022 1,86x
EV / Sales 2023 3,77x
Nbr of Employees 2 700
Free-Float 90,6%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 149,95 $
Average target price 213,67 $
Spread / Average Target 42,5%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-40.96%59 644
IQVIA HOLDINGS INC.-23.78%40 704
LONZA GROUP AG-31.83%40 011
SEAGEN INC.16.50%33 154
CELLTRION, INC.-9.60%19 031
ALNYLAM PHARMACEUTICALS, INC.-12.58%17 911